Evvy · Series B
Pioneering precision care for vaginal health through advanced microbiome testing and personalised treatment plans.
Amount
$40M
Round
Series B
Valuation
—
Announced
Sep 2026
Investors
Lead investor
Catalio Capital ManagementNotes
auto-discovered via firecrawl